Факторы риска развития спорадического рака яичников
https://doi.org/10.17650/1994-4098-2010-0-1-46-50
Аннотация
Список литературы
1. Манухин И.Б., Высоцкий М.М., Кушлинский Н.Е. Молекулярно- биологические факторы в патогенезе и хирургическом лечении опухолей яичников. М.: Династия, 2007.
2. Урманчеева А.Ф., Мешкова И.Е. Вопросы эпидемиологии и диагностики рака яичников. Практ онкол 2000;(4):7—13.
3. Ries L., Miller B.A., Hankey B.F. SEER cancer statistics review 1973— 1991. National Institut of Health 1994. 4. World Cancer Research Fund. Ovary, food, nutrition, and the prevention of cancer: a global perspective. Washington, 1997. p. 288—93.
4. Howe H.J., Wingo P.A., Thun M.J. et al. Annual report to the nation on the status of cancer. Int J Gynecol Cancer 2001;(93):824—42.
5. Liede A., Karlan B., Baldwin R. Cancer incidence in a population of Jewish women at risk of ovarian cancer. J Clin Oncol 2002;20:1570—7.
6. Menczer J., Liphshittz I., Barchana M. A decreasing incidence of ovarian carci- noma in Israel. Int J Gynecol Cancer 2006;(16):41—4.
7. Runnenbaum I.B., Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 2001;123:73—9.
8. Whittemore A.S., Harris R., Itnyre J. et al. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case control studies. Am J Epidemiol 1992;136:1212—20.
9. Cooper G.S., Schildkraut J.M., Whittemore A.S. et al. Pregnancy recen- cy and risk of ovarian cancer. Cancer Caus Contr 1999;10:397—402.
10. Venn A., Watson L., Bruinsma F. et al. Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 1999;354:1586—90.
11. Zreik T.G., Ayoub C.M., Hannoun A. Fertility drugs and risk of ovarian cancer: dispelling the myth. Curr Opin Obstet Gynecol 2008;20(3):313—9.
12. Risch H.A., Marret L.D., Howe G.R. Parity, contraception, infertility and the risk of epithelial ovarian cancer. Am J Epidemiol 1994;140:585—91.
13. Итон С.Б., Хэтчер Р.А., Коннер М.Дж. и др. Рак женских репродуктивных органов и процесс эволюции. Вопр онкол 1991;37(9— 10):899—907.
14. Vessey M., Painter R. Oral contra- ceptive use and cancer. Findings in a large cohort study, 1968—2004. Br J Cancer 2006 [Epub ahead of print].
15. NIH Consensus Development Conference Statement. Ovarian cancer: screening, treatment and follow-up. Gynecol Oncol 1994;55:4—14.
16. Hankinson S.E., Hunter D.J., Colditz G.A. et al. Tubal ligation, hys- terectomy and risk of ovarian cancer: a prospective study. JAMA 1993;270(23):2813—8.
17. Riman Т., Perssont N.S. Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence. Clin Endocrinol Oxf 1998;49(6):695—707.
18. WHO classification of tumours. Lyon: IARCPRESS, 2003.
19. Mahdavi A., Pejovic T., Nezhat F. Induction of ovulation and ovarian can- cer: a critical review of the literature. Fertil Steril 2006;85(4):819—26.
20. Garg P.P., Kerlikowske K., Subal L. Hormone replacement therapy and the risk of epithelial ovarian carcinoma: a meta-analysis. Obstet Gynecol 1998;92:472—9.
21. Purdie D.M., Bain C.J., Siskind V. Hormone replacement therapy and the risk of epithelial ovarian cancer. Br J Cancer 1999;81:559—64.
22. Shu X.O., Gao Y.T., Yuan J.M. et al. Dietary factors and epithelial ovarian cancer. Br J Cancer 1989;59:92—6.
23. Манухин И.Б., Высоцкий М.М. Современные методы профилактики рака яичников. Вопр гинекол акуш перинатол 2003;2(3):37—44.
24. Greer J.B., Howe H.J., Wingo P.A. et al. Anthropometry and the risk of epithelial ovarian cancer. Cancer 2006; [Epub ahead of print]
25. Engeland A., Tretli S., Bjorge T. Height, body mass index, and ovarian cancer: a follow-up of 1,1 million Norwegian women. J Natl Cancer Inst 2003;95(16):1244—8.
26. Weiderpass E., Margolis K.L., Sandin S. Prospective study of physical activity in different periods of life and the risk of ovarian cancer. Int J Cancer 2006 [Epub ahead of print].
27. Bertone E.R., Wilett W., Rosner B.A. et al. Prospective study of recreational physical activity and ovarian cancer. J Natl Cancer Inst 2001;93(12):942—8.
28. Edefonti V., Decarli A., La Vecchia C. Nutrient dietary patterns and the risk of breast and ovarian cancers. Int J Cancer 2008;122(3):609—13.
29. Mommers M., Schouten L.J., Goldbohm R.A. et al. Dairy consump- tion and ovarian cancer risk in the Netherlands Cohort Study on Diet and Cancer. Br J Cancer 2005 [Epub ahead of print].
30. Mommers M., Schouten L.J., Goldbohm R.A. et al. Consumption of vegetables and fruits and risk of ovarian carcinoma. Cancer 2005;104(7):1512—9.
31. Koushik A., Hunter D.J., Spiegelman D. Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies. Int J Cancer 2006 [Epub ahead of print].
32. Wood C.E., Register T.C., Franke A.A. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res 2006;66(2):1241—9.
33. Rossi M., Negri E., Lagiou P. Flavonoids and ovarian cancer risk: A case-control study in Italy. Int J Cancer 2008 [Epub ahead of print].
34. Jordan S.J., Whiteman D.C., Purdie D.M. Does smoking increase risk of ovarian cancer? A systematic review. Gynecol Oncol 2006;[Epub ahead of print].
35. Genkinger J.M., Hunter D.J., Spiegelman D. Alcohol intake and ovari- an cancer risk: a pooled analysis of 10 cohort studies. Br J Cancer 2006 [Epub ahead of print].
36. Peterson N.B., Trentham-Dietz A., Newcomb P.A. Alcohol consumption and ovarian cancer risk in a population-based case-control study. Int J Cancer 2006 [Epub ahead of print].
37. Baker J.A., Odunuga O.O., Rodabaugh K.J. et al. Active and passive smoking and risk of ovarian cancer. Int J Gynecol Cancer 2006;16(Suppl):211—8.
Рецензия
Для цитирования:
Высоцкий М.М., Дигаева М.А. Факторы риска развития спорадического рака яичников. Опухоли женской репродуктивной системы. 2010;(1):46-50. https://doi.org/10.17650/1994-4098-2010-0-1-46-50
For citation:
Vysotsky M.M., Digayeva M.A. Risk factors for sporadic ovarian cancer. Tumors of female reproductive system. 2010;(1):46-50. (In Russ.) https://doi.org/10.17650/1994-4098-2010-0-1-46-50